<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Occupational asthma: Pathogenesis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Occupational asthma: Pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Occupational asthma: Pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David I Bernstein, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hille Suojalehto, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter J Barnes, DM, DSc, FRCP, FRS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The label "asthma in the workplace" encompasses several entities: (1) asthma exacerbated at work by various environmental conditions; (2) occupational asthma; and (3) variants (eg, eosinophilic bronchitis) [<a href="#rid1">1</a>]. Occupational asthma is a type of work-related asthma that is caused by immunologic (identified or presumed) and nonimmunologic stimuli present in the workplace. [<a href="#rid2">2</a>].</p><p>The pathogenesis and pathology of occupational asthma will be reviewed here. Issues related to other aspects of occupational asthma are discussed separately. (See  <a class="medical medical_review" href="/d/html/537.html" rel="external">"Occupational asthma: Definitions, epidemiology, causes, and risk factors"</a> and  <a class="medical medical_review" href="/d/html/550.html" rel="external">"Occupational asthma: Clinical features, evaluation, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">TYPES</span><span class="headingEndMark"> — </span>Two main types of occupational asthma have been recognized [<a href="#rid1">1,3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Immunologically-mediated. This type includes immunoglobulin E (IgE) and non-IgE-mediated responses following chronic exposure and respiratory sensitization to high or low molecular weight agents.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nonimmunologic, irritant-mediated, also called irritant-induced asthma. This type includes reactive airways dysfunction syndrome (RADS) caused by a single high-level exposure to an irritant, irritant-induced asthma caused by multiple high-level exposures to an irritant, and possibly asthma caused by chronic lower level of exposure, although the latter is controversial. (See  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p></p><p>Some occupational agents, such as diisocyanates, may induce asthma through more than one mechanism. As an example, asthma may develop in some subjects after an accidental high-level diisocyanate exposure (eg, spill) by causing acute airway injury resulting in reactive airways dysfunction syndrome (RADS). In others, respiratory sensitization to diisocyanate develops with lower levels of exposure. Exposure to high levels of diisocyanates causing irritant-induced occupational asthma can also promote the development of immunologic occupational asthma caused by diisocyanates. (See  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p>The various types of occupational asthma may include different phenotypes or endotypes [<a href="#rid4">4</a>]. As an example, in an analysis of 187 patients with diisocyanate asthma (DA), different clusters were populated, similar to common asthma, with the largest cluster including the youngest patients with the shortest duration of exposure to the sensitizers, while another cluster included older male patients with worse lung function and longer occupational exposure [<a href="#rid5">5</a>]. This suggests that occupational asthma (as probably many others) is phenotypically heterogeneous. There are several phenotypes (clinical presentations) and endotypes (mechanistic pathways) of occupational asthma that are characterized by their clinical features, their pathogenesis and inflammatory profile [<a href="#rid6">6</a>]. However, more research is needed to characterize these phenotypes/endotypes.</p><p>This variation in features among patients with occupational asthma is supported by an international study of 1167 subjects with occupational asthma to high (n = 544) and low (n = 623) molecular weight agents, confirmed by specific inhalation challenges [<a href="#rid7">7</a>]. Multivariate logistic regression analysis showed significant associations between occupational asthma caused by high molecular weight agents and work-related rhinitis, conjunctivitis, atopy, and early asthmatic reactions. By contrast, occupational asthma to low molecular agents was associated with chest tightness at work, daily sputum production, and late asthmatic reactions. Although assessed in a lower proportion of subjects, baseline sputum inflammatory profiles were similar in the two groups, but occupational asthma caused by high molecular weight agents showed higher baseline blood eosinophils and a greater postchallenge increase in fractional nitric oxide. Postchallenge, a higher proportion of subjects with occupational asthma to high molecular weight agents showed a switch from a paucigranulocytic to an eosinophilic pattern in their sputum. Thus, the best biomarkers in occupational asthma are associated with a type 2 lymphocyte response (eg, blood and sputum eosinophils, exhaled nitric oxide), but we need to know more about potential markers for other types of occupational asthma [<a href="#rid8">8</a>].</p><p>Comorbidities can influence occupational asthma phenotypes, as shown by the description of occupational asthma-chronic obstructive pulmonary disease (COPD) overlap (OACO) in 13.8 percent of a cohort of 304 workers with a diagnosis of occupational asthma [<a href="#rid9">9,10</a>]. Those with OACO (forced expiratory volume in one second/forced vital capacity [FEV<sub>1</sub>/FVC] &lt;70 percent and smoking history ≥10 pack-years) were older, took higher doses of inhaled corticosteroids, had lower presence of atopy and lower sputum eosinophil counts after specific inhalation challenge.</p><p class="headingAnchor" id="H3"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>In the case of immunologically mediated occupational asthma, the pathology in the airways at the time of exposure is similar to that seen in patients with nonoccupational asthma (see  <a class="medical medical_review" href="/d/html/522.html" rel="external">"Pathogenesis of asthma", section on 'Airway inflammation'</a>). Nonimmunologic irritant-mediated occupational asthma is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p>The pathologic abnormalities associated with occupational asthma persist for weeks to years after cessation of exposure. One study examined the bronchial biopsies of 18 subjects with occupational asthma after cessation of exposure for a period of 3 to 24 weeks [<a href="#rid11">11</a>]. Eleven subjects had disease due to exposure to high molecular weight compounds, and seven to low molecular weight (LMW) compounds. Extensive epithelial desquamation, epithelial cell ciliary abnormalities, smooth muscle hyperplasia, and subepithelial fibrosis were found, and the numbers of total inflammatory cells, eosinophils, and lymphocytes were increased compared to healthy controls  (<a class="graphic graphic_picture graphicRef60266" href="/d/graphic/60266.html" rel="external">picture 1</a>). Similar findings were described in reports of subjects with isocyanate- and Western red cedar-related asthma [<a href="#rid12">12,13</a>]. Animal models have suggested that profibrotic cytokines such as interleukin (IL)-13, can be involved in these changes although a direct toxicity of some agents against epithelial cells can be involved in the remodelling process [<a href="#rid14">14,15</a>].</p><p>Subjects with isocyanate-induced asthma show a reduction in subepithelial fibrosis, but inflammatory cell infiltration of the airways after removal from exposure can persist for a period ranging from 5 to 21 months [<a href="#rid16">16</a>]. The course of airway hyperresponsiveness parallels that of airway inflammation, suggesting that airway inflammation contributes to the persistence of hyperresponsiveness. It is possible that inflammatory and remodeling airway changes precede the development of clinical features of occupational asthma, as shown in asthma induced by common allergens, but this remains to be further documented [<a href="#rid17">17</a>].</p><p>Persistent airway inflammation and remodeling exists even in subjects whose occupational asthma is presumed to be cured. In an observational study, 133 subjects with occupational asthma were evaluated at a mean of nine years after cessation of the exposure [<a href="#rid18">18</a>]. Among those from whom induced sputum was obtained (n = 84), eosinophils were increased (≥2 percent) in 18 percent, including 3 of the 20 subjects who were considered cured, based on resolution of symptoms, no need for respiratory medication, normal airway caliber, and nonallergic airway responsiveness. Neutrophils were increased (≥61 percent of cells in induced sputum) in 45 percent (including nine of those considered cured). Furthermore, 10 of the subjects considered cured, who had no evidence of bronchial eosinophilia on induced sputum, underwent bronchoscopy with bronchial biopsies at a mean of 14 years after cessation of exposure. Compared to controls, subjects with prior occupational asthma had more transforming growth factor (TGF)-beta1 and eosinophil cationic protein (ECP) positive cells, increased subepithelial fibrosis, and decreased distance between the epithelium and airway smooth muscle [<a href="#rid19">19</a>]. These findings suggest that permanent inflammatory and structural changes persist many years after stopping exposure to a respiratory sensitizer. The reason for the persistence of eosinophilic inflammatory changes many years after stopping exposure is unknown.</p><p>Acute changes in the airways of subjects with reactive airways dysfunction syndrome (RADS) or irritant-induced asthma consist of rapid denudation of the mucosa with fibrinohemorrhagic exudate and swelling in the submucosa  (<a class="graphic graphic_picture graphicRef53602" href="/d/graphic/53602.html" rel="external">picture 2</a>) [<a href="#rid20">20</a>]. This is followed by regeneration of the epithelium with proliferation of basal and parabasal cells and persistent subepithelial edema [<a href="#rid20">20</a>]. Similar findings have been described in an animal model of RADS due to chlorine exposure [<a href="#rid21">21,22</a>]. Furthermore, bronchial biopsies from subjects with persistent asthma symptoms two years following chlorine-induced RADS show a thickened basement membrane with reticulocollagenic fibrosis of the bronchial wall  (<a class="graphic graphic_picture graphicRef62311" href="/d/graphic/62311.html" rel="external">picture 3</a>) [<a href="#rid23">23</a>]. In irritant-induced asthma due to multiple exposures to an irritant, an inflammatory infiltrate with eosinophils and lymphocytes is found, as well as diffuse deposition with collagen fibers [<a href="#rid24">24</a>]. Even many years after the inhalational accident, induced sputum can show increased levels of mediators involved in inflammation and airway remodeling [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p>Evidence of eosinophilic and neutrophilic inflammation and also airway remodeling can persist for several years following acute irritant-induced asthma. Ten subjects with irritant-induced asthma (mean interval of 10.9 years, minimum of 4 years, since the inhalational accident) underwent bronchoscopy followed by bronchoalveolar lavage and bronchial biopsies [<a href="#rid26">26</a>]. The most significant difference in tissue morphometry was the increase in basement membrane thickness in subjects with irritant-induced asthma compared with the healthy controls and subjects with mild asthma. The detachment of epithelium was increased in subjects with irritant-induced asthma, although not significantly so. Also, the number of TGF-beta1 positive cells and ECP positive cells was increased by comparison with normal controls and comparable to subjects with common asthma. Finally, the levels of cells (neutrophils and eosinophils) and of several mediators that reflect an inflammatory and remodeling effect were significantly higher in the bronchoalveolar lavage than in normal controls and comparable or even higher than in subjects with common asthma.</p><p class="headingAnchor" id="H4"><span class="h1">GENETICS</span><span class="headingEndMark"> — </span>Genetic loci associated with nonoccupational asthma have been investigated as susceptibility markers for occupational asthma, primarily in workers with diisocyanate asthma (see  <a class="medical medical_review" href="/d/html/561.html" rel="external">"Genetics of asthma"</a>) [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Innate immunity and immunoregulation</p><p class="bulletIndent1"><span class="glyph">●</span>Type 2 lymphocyte differentiation</p><p class="bulletIndent1"><span class="glyph">●</span>Epithelial biology and mucosal immunity</p><p class="bulletIndent1"><span class="glyph">●</span>Lung function (airway hyperresponsiveness), airway remodeling, and disease severity</p><p></p><p>The human leukocyte antigen (HLA) system, which is synonymous with the major histocompatibility complex (MHC), encodes a variety of cell surface markers, antigen-presenting molecules, and other proteins involved in immune function. Studies of genes involved in immunoregulation have shown associations between HLA Class II antigens and various types of occupational asthma [<a href="#rid27">27</a>]. Several examples of HLA associates (eg, DR3, DQ5, DQA1, DQB1, DR1) have been described in the case of workers exposed to diisocyanates, Western red cedar, platinum salts, laboratory animals, and anhydrides [<a href="#rid27">27</a>]. In a study of 140 diisocyanate-exposed workers, diisocyanate asthma was associated with HLA Class I (HLA-B and HLA-E) and Class II single nucleotide polymorphisms (SNPs), not identified in prior studies [<a href="#rid28">28</a>]. The associations with HLA antigens have biological implications in that they provide evidence for a specific immunological response and for T cell involvement in the development of occupational asthma caused by low molecular weight compounds.</p><p>Several studies support a role for antioxidant genes, such as the glutathione S-transferases (eg, GSTP1 and GSTM1) and N-acetyltransferase (NAT1, NAT2), in the development of occupational asthma [<a href="#rid28">28,29</a>]. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Glutathione S-transferases belong to a family of enzymes that detoxify chemical substances in the body. The GSTM1 null genotype is associated with an approximately two fold increased risk of diisocyanate-induced asthma [<a href="#rid30">30</a>]. In addition, GSTM1 null and GSTM3 AA genotypes are significantly related to late asthmatic reactions induced by diisocyanates [<a href="#rid30">30</a>]. On the other hand, homozygosity for the GSTP1*Val allele may provide a protective effect against asthma in workers exposed to isocyanate [<a href="#rid3">3,30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>NAT1 also helps to metabolize drugs and chemicals. The slow acetylator genotype increases the risk of asthma in workers exposed to toluene diisocyanate (TDI) [<a href="#rid3">3,31</a>]. NAT2 SNPs and SNP combinations have been associated with a higher likelihood of diisocyanate asthma [<a href="#rid31">31,32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genetic variants in manganese superoxide dismutase (SOD2) and microsomal epoxide hydrolase (EPHX1) and their interactions may contribute to development of diisocyanate asthma [<a href="#rid33">33</a>].</p><p></p><p>Associations have also been found for other genes (eg, toll-like receptors, IL-4 receptor, IL-13, CD14, neurokinin 2 receptor, alpha-catenin) in patients with occupational asthma due to diisocyanates [<a href="#rid34">34-36</a>]. An association between diisocyanate asthma and two linked alpha-catenin gene variants was identified by GWAS in Korean workers and confirmed in a second worker population [<a href="#rid37">37,38</a>]. Another GWAS performed in White workers with diisocyanate asthma identified 11 SNPs exceeding genome-wide significant associations with diisocyanate asthma [<a href="#rid39">39</a>]. A next-generation sequencing (NGS) study performed in the same population identified four disease-associated SNPs with regulatory effects on gene expression [<a href="#rid40">40</a>]. In addition, genetic variations in tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1, prostaglandin-endoperoxide synthase (PTGS) 1, and PTGS2 are associated with diisocyanate asthma susceptibility [<a href="#rid41">41</a>].</p><p>Work-related exposure to occupational chemicals could result in epigenetic modification of specific genes associated with airway inflammation. The interferon (IFN)-gamma gene promoter region was significantly hyper-methylated in a study of workers with diisocyanate asthma in comparison to asymptomatic workers, suggesting that epigenetic effects could play an important mechanistic role [<a href="#rid42">42</a>].</p><p>Gene-environment interactions are difficult to study in the workplace. A cross-sectional study performed in laboratory animal workers demonstrated that those workers with high endotoxin exposure and a known CD14 endotoxin responsive genotype had significantly lower forced expiratory volume in one second (FEV<sub>1</sub>), suggesting that workers with the latter genotype are at greatest risk [<a href="#rid43">43</a>].</p><p>An unbiased genome-wide association study followed by next-generation sequencing of workers with diisocyanate asthma identified five disease-associated variants (proximal to ATF3, cadherin 17, FAM71A, and TACR1 genes) with gene regulatory effects [<a href="#rid40">40</a>]. Such an approach could help elucidate novel pathogenic mechanisms in the future.</p><p class="headingAnchor" id="H5"><span class="h1">IMMUNOLOGIC MECHANISMS</span><span class="headingEndMark"> — </span>Agents that induce occupational asthma by immunologic mechanisms are characterized by a latency period between exposure and the development of symptoms. Immunologic occupational asthma affects only a small proportion of exposed subjects, but in these patients, exposure to a minute quantity of the offending agent can lead to a severe asthmatic reaction. While some compounds, mostly metal salts and those containing protein, induce asthma through the production of specific IgE antibodies, the immunologic mechanism(s) that pertain to other agents (most chemicals) have not been identified.</p><p>Specific IgE-mediated responses to work-place sensitizers are considered to be involved in the majority of cases of occupational asthma, particularly when caused by high molecular weight (HMW) agents [<a href="#rid44">44</a>]. Low molecular weight (LMW) agents are, however, more likely to cause non-IgE-mediated disease. In this regard, bronchial biopsies obtained after inhalation challenge with diisocyanates did not reveal an expression of messenger RNA for IgE ε (epsilon) chains or interleukin (IL)-4, suggesting that IgE is not usually involved in this type of OA [<a href="#rid45">45</a>].</p><p>T lymphocytes appear to play a major role in the pathophysiology of occupational asthma. When causative agents are inhaled, antigen-presenting cells collect and process the antigen, and then migrate to regional lymph nodes where the antigen is presented to T helper cells, which are responsible for the initiation of the immune response. In a series of nonsmoking patients with occupational asthma, a triple-color immunohistofluorescence labelling technique was used on cryosections of bronchial samples to demonstrate a significantly increased bronchial density of regulatory T cells, effector T cells, proliferative T cells, and activated CD8+ T cells [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/d/html/3980.html" rel="external">"The adaptive cellular immune response: T cells and cytokines"</a>.)</p><p>The most common route of exposure in occupational asthma is inhalational. However, skin exposure has also been incriminated in the onset of sensitization to diisocyanates and other low molecular sensitizers [<a href="#rid47">47,48</a>].</p><p class="headingAnchor" id="H6"><span class="h2">IgE-mediated</span><span class="headingEndMark"> — </span>HMW agents (eg, latex, animal proteins, and flour) act as complete antigens and induce the production of specific IgE antibodies. Certain LMW occupational agents, including platinum salts, trimellitic anhydride, and other acid anhydrides, can also induce specific IgE antibodies, probably by acting as haptens and binding with proteins to form functional antigens  (<a class="graphic graphic_table graphicRef66185" href="/d/graphic/66185.html" rel="external">table 1</a>). Several human leukocyte antigen (HLA) associations have been described, but the results have not been convincingly reproduced [<a href="#rid49">49</a>].</p><p>Regardless of the characteristics of the inciting antigen, reactions between specific IgE antibodies and antigens lead to a cascade of events that results in an influx of inflammatory cells into the airway and the release of inflammatory mediators.</p><p>Inhalational challenge with culprit antigens in sensitized individuals generally results in an isolated early reaction, although inhalation challenge may sometimes result in a late reaction or a biphasic reaction  (<a class="graphic graphic_figure graphicRef56482" href="/d/graphic/56482.html" rel="external">figure 1</a>) [<a href="#rid50">50,51</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>An isolated early asthmatic reaction occurs within a few minutes after an inhalation challenge, reaches it maximum within one-half hour, and subsides within 1 to 1.5 hours.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A late reaction occurs four to six hours after a challenge, reaches maximal intensity within 8 to 10 hours, and subsides after 24 to 48 hours.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A biphasic reaction is a combination of an early and a late reaction.</p><p></p><p>Specific inhalation challenges can also cause atypical temporal patterns of airflow limitation [<a href="#rid51">51</a>]. Although occupational asthma due to high-molecular-weight agents is frequently if not always associated with increased levels of serum specific IgE antibodies, this test alone should not be considered as confirming the disease. Confirming the effect of exposure to the agent on airway function should always be recommended for diagnostic purposes [<a href="#rid52">52</a>].</p><p class="headingAnchor" id="H7"><span class="h3">Detection of IgE</span><span class="headingEndMark"> — </span>The ability to detect specific IgE antibodies in patients with occupational asthma to low molecular weight agents may be technically difficult [<a href="#rid53">53,54</a>]. Specific IgE antibodies to toluene diisocyanate (TDI) have been reported in 0 to 50 percent of workers with TDI induced asthma [<a href="#rid55">55</a>]. This variation has been attributed to several factors:</p><p class="bulletIndent1"><span class="glyph">●</span>The short half-life of the specific IgE antibodies to TDI of about two days [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The appearance of new antigenic determinants after the binding of specific IgE to TDI-human albumin conjugate [<a href="#rid57">57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of different carrier proteins. As an example, human serum albumin is sometimes used for conjugation with TDI, while keratin, which is found in the lungs and skin, has been found to conjugate with hexamethylene diisocyanate in studies using human epithelial cell lines and endobronchial biopsy samples [<a href="#rid58">58</a>]. Whether the TDI-keratin conjugate would give a higher proportion of specific IgE antibodies in patients with TDI induced asthma remains to be seen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The different methods of conjugation of the haptenic low molecular weight antigen with a carrier and the methods of assay [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pathogenic mechanisms other than IgE mediation are causing occupational asthma. (See <a class="local">'Non-IgE-mediated reactions'</a> below.)</p><p></p><p>Workers with the AA genotype of the 46 A&gt;G polymorphism of the beta 2-adrenergic receptor gene (ADRB2) who were exposed to TDI had significantly higher serum levels of TDI-albumin-specific IgE than those with GG genotype, suggesting that ADRB2 polymorphism may affect IgE-specific sensitization to TDI [<a href="#rid59">59</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Non-IgE-mediated reactions</span><span class="headingEndMark"> — </span>Many LMW agents can induce occupational asthma after a latent period (eg, acid anhydrides, certain metals, diisocyanates), suggestive of immunologic mediation. Some LMW agents produce pathogenic IgE via conjugation with a hapten (see <a class="local">'IgE-mediated'</a> above). However, many LMW agents are NOT associated with production of specific IgE. The exact nature of the non-IgE immunologic mechanisms remains unclear.</p><p>The ability of a LMW agent to induce asthma may depend upon its chemical structure [<a href="#rid60">60-62</a>]. As examples, certain transitional metals form coordination complexes that may chelate human proteins (eg, chromium, cobalt, nickel, platinum), and some organic substances have two or more reactive chemical groups (eg, amines, cyanates) that are highly reactive with human macromolecules. The agents with two or more reactive chemical groups, also known as bifunctional bases, (eg, diisocyanate) have a much higher propensity to induce asthma than those with a single reactive group, also known as a monofunctional base (eg, monoisocyanates) [<a href="#rid61">61</a>].</p><p class="headingAnchor" id="H9"><span class="h3">Evidence against IgE mediation</span><span class="headingEndMark"> — </span>Evidence against IgE mediation in occupational asthma induced by LMW agents includes the following observations: affected workers are typically nonatopic, the pattern of airflow limitation following inhalational challenge is different from that of IgE-mediated occupational asthma, and the IgE molecules identified lack the ability to cause passive sensitization.</p><p>Specific inhalation challenge tests with LMW agents more commonly induce late asthmatic reactions than IgE-mediated occupational asthma [<a href="#rid7">7,51</a>]. Atypical reactions are often observed with LMW agents  (<a class="graphic graphic_figure graphicRef65163" href="/d/graphic/65163.html" rel="external">figure 2</a>): a progressive type with onset during or minutes after exposure, progressing to a maximum reaction five to six hours later, a continuous asthmatic reaction with no remission between the early and the late phases (square-waved), and a prolonged immediate reaction. (See  <a class="medical medical_review" href="/d/html/525.html" rel="external">"Bronchoprovocation testing", section on 'Antigen challenge'</a>.)</p><p>Patients with occupational asthma due to non-IgE-mediated reactions may produce IgE antibodies that are reflective of prior exposure, rather than being integral to disease pathogenesis. As an example, Western red cedar-related asthma, caused by sensitization to the LMW agent plicatic acid, results in production of IgE antibodies to plicatic acid in approximately 20 percent of affected subjects [<a href="#rid63">63</a>]. However, these antibodies do not passively sensitize human lung fragments [<a href="#rid63">63,64</a>]. Based on the high proportion of patients without evidence of specific IgE production and the lack of passive sensitization, it is likely that non-IgE mechanisms are responsible for the majority of plicatic acid-induced occupational asthma.</p><p>In contrast, among workers with suspected diisocyanate-induced asthma, having a higher level of specific IgE to diisocyanates is highly specific for identifying those affected with occupational asthma as confirmed by specific inhalation challenges [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H10"><span class="h3">Evidence for cell-mediated responses</span><span class="headingEndMark"> — </span>Most studies have found that cellular mediated immunological mechanisms contribute to the pathogenesis of non-IgE-mediated immunologic (low molecular weight antigen) occupational asthma. Bronchial biopsies from subjects with diisocyanate and red cedar-related asthma show large numbers of activated T lymphocytes adjacent to bronchi, suggesting that these cells play a direct role in mediating airway inflammation [<a href="#rid12">12,13</a>].</p><p>Diisocyanate-induced asthma, a non-IgE-mediated disease in most instances, appears to be associated with increased recruitment and activation of pulmonary lymphocytes:</p><p class="bulletIndent1"><span class="glyph">●</span>Monocyte chemoattractant protein-1, a T cell chemoattractant, is elaborated in increased amounts by peripheral blood mononuclear cells from patients with occupational asthma due to diisocyanates [<a href="#rid65">65</a>]. Among workers exposed to diisocyanate, production of monocyte chemoattractant protein-1 (MCP-1) by peripheral blood mononuclear cells in response to stimulation with diisocyanate-human serum albumin (DIISO-HSA) was more sensitive and specific for diisocyanate-induced asthma than serum levels of specific IgE [<a href="#rid65">65</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When bronchial biopsy specimens were obtained by fiberoptic bronchoscopy 24 hours after diisocyanate inhalational challenge, bronchial recruitment of IL-5, CD25 (soluble IL-2 receptor), and CD4 positive cells was noted in patients with diisocyanate-induced asthma [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast to most studies that suggest mediation by CD4 T cells, one study of bronchial biopsies from patients with diisocyanate-induced asthma found that the majority of T cells exhibited the CD8 phenotype and produced interferon (IFN)-gamma and interleukin (IL)-5, with very few clones producing IL-4 [<a href="#rid66">66</a>]. However, there was evidence of an eosinophilic involvement.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, bronchial biopsies of workers with occupational asthma to methylene diphenyl diisocyanate (MDI) demonstrated an increase in eosinophil cationic protein and increased basophil release of histamine [<a href="#rid67">67</a>]. Sputum eosinophil counts correlated with IL-8 and MMP-9 levels.</p><p></p><p>Other evidence that T lymphocytes play a role in occupational asthma induced by LMW compounds comes from studies of peripheral blood cells obtained from patients with occupational asthma due to various LMW agents.</p><p class="bulletIndent1"><span class="glyph">●</span>In patients with asthma associated with Western red cedar, nickel, or cobalt, proliferation of peripheral blood lymphocytes occurs following incubation with the appropriate antigen, suggesting the presence of a cell-mediated hypersensitivity reaction [<a href="#rid68">68,69</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In diisocyanate-induced asthma, CD8-positive T lymphocytes and eosinophils are increased in the peripheral blood of subjects during late asthmatic reactions induced by challenge with the agent [<a href="#rid70">70</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Platinum salt sensitization in patients with asthma due to platinum salts is associated with an expansion of T-lymphocytes bearing specific T cell receptors (TCRs: Vb21.3, Vb11 and Va2a) [<a href="#rid71">71</a>]. Furthermore, stimulation of peripheral blood mononuclear cells with sodium hexachloroplatinate leads to increases in expression of certain specific TCRs.</p><p></p><p class="headingAnchor" id="H11"><span class="h3">Specific IgG antibodies</span><span class="headingEndMark"> — </span>Exposure to occupational allergens can induce specific IgG responses, and specific IgG antibodies may play a role in low molecular weight agent-induced occupational asthma, although their exact role is unknown. As an example, specific IgG antibodies have been identified in patients with occupational asthma due to diisocyanates [<a href="#rid65">65</a>]. However, they may represent an immunological response to current or past exposure and may not be directly related to the pathogenic mechanisms in diisocyanate-induced asthma [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Animal models</span><span class="headingEndMark"> — </span>Animal models have been developed to examine the physiopathology of immunologic occupational asthma [<a href="#rid27">27</a>]. Unique effector mechanisms may exist for different antigens or types of antigens (haptens versus protein antigens) [<a href="#rid72">72</a>]. The species, strain, age, dose of allergen, and routes of sensitization and challenge may influence the model. Effector mechanisms may also differ depending on the asthmatic reaction being considered (ie, airway obstruction or eosinophil infiltration). A mouse model demonstrated that toluene-diisocyanate (TDI)-induced airway inflammation was associated with increased thymic stromal lymphopoietin (TSLP) in mouse lung tissues. Treatment with TSLP neutralizing antibody resulted in reduction of inflammatory cells and levels of IFN-gamma, IL-4, and IL-17 in bronchoalveolar lavage, suggesting that reactive chemicals could initiate airway inflammation via upstream generation of regulatory cytokines (ie, TSLP) in respiratory epithelial tissue [<a href="#rid73">73</a>].</p><p>Data from animal models support a role for Type 2 lymphocytes and their cytokines in some forms of occupational asthma [<a href="#rid74">74,75</a>]. In addition, T regulatory lymphocytes (Tregs) isolated from TDI-sensitized mice, were significantly more suppressive than those from nonsensitized controls, supporting a role for Tregs in TDI sensitization [<a href="#rid76">76</a>]. When Tregs were depleted before sensitization, the sensitization response was enhanced. Initial dermal sensitization of mice to TDI, followed by repeated intranasal TDI challenges, was required to elicit airway hyperresponsiveness and robust Type 2 responses. Thus, early dermal exposure to chemicals could play an important role in the pathogenesis of TDI asthma [<a href="#rid77">77</a>].</p><p class="headingAnchor" id="H13"><span class="h1">NONIMMUNOLOGIC MECHANISMS</span><span class="headingEndMark"> — </span>Agents that induce asthma by nonimmunologic mechanisms are characterized by the absence of a latency period. Three mechanisms may explain the development of symptoms in these patients:</p><p class="bulletIndent1"><span class="glyph">●</span>Subjects without any prior respiratory difficulties develop symptoms of asthma within a few hours of acute, high-level irritant exposure and may have evidence of nonspecific airway hyperresponsiveness for more than three months. Acute airway injury from accidental exposure to high dose of irritants such as chlorine, ammonia, smoke, or acetic acid may lead to reactive airways dysfunction syndrome (RADS). Furthermore, the development of irritant-induced asthma due to diisocyanates may promote sensitization to these compounds [<a href="#rid78">78,79</a>]. (See  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p></p><p class="bulletIndent1">The underlying mechanism of RADS is not known, but it has been postulated that extensive denudation of the epithelium results in airway inflammation because of a loss of epithelial derived relaxing factors, exposure of the nerve endings leading to neurogenic inflammation, and nonspecific activation of mast cells with release of inflammatory mediators and cytokines [<a href="#rid80">80</a>]. Epithelial damage may also result in the marked airway remodeling observed in these patients, particularly the intense subepithelial fibrosis which is probably responsible for the reduced reversibility of airflow obstruction observed in this condition [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some low molecular weight agents have pharmacologic properties that may cause bronchoconstriction. As examples, diisocyanates may block beta-2 adrenergic receptors, and plicatic acid in high concentrations may activate complement [<a href="#rid78">78,81</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diisocyanates and other occupational agents may stimulate sensory nerves to release substance P and other neuropeptides and may inhibit the neutral endopeptidases that normally inactivate these substances [<a href="#rid82">82</a>]. Neuropeptides affect a variety of cells in the airways, resulting in cough, smooth muscle contraction, and mucus production [<a href="#rid83">83</a>].</p><p></p><p>The role of long-term irritant exposure at work in the development of asthma remains to be elucidated, but some observations suggest an effect of such exposure in work-related asthma. The proposed underlying mechanisms include oxidative stress, neurogenic inflammation, and dual irritant and adjuvant effects [<a href="#rid84">84</a>].</p><p>In regard to occupational asthma induced by exposure to laboratory animals, exposure to endotoxins is associated with a higher prevalence of wheezing, but not with asthma, as assessed with <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a> challenge or self-reported asthma [<a href="#rid85">85</a>].</p><p>Some agents can induce asthma through both immunological and nonimmunological mechanisms. Diisocyanate is the best example. Toluene diisocyanate-induced asthma (through sensitization) has been reported in individuals who have previously been heavily exposed during a chemical spill [<a href="#rid79">79,86</a>]. While the immune system plays an important role in occupational asthma, inflammation may be a secondary response rather than the underlying cause of pathogenesis. Multiple mechanisms involving airway epithelial injury and repair, structural remodeling, oxidative stress, and neurogenic factors may also contribute to the pathogenesis [<a href="#rid87">87</a>].</p><p class="headingAnchor" id="H3986872791"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112673.html" rel="external">"Society guideline links: Occupational asthma"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Occupational asthma is a disease characterized by variable airflow limitation, airway hyperresponsiveness, and inflammation resulting from exposures to agents present in the workplace. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational asthma types</strong> – Two main types of occupational asthma have been recognized: immunologically mediated (with or without evidence of participation of IgE) and nonimmunologic, irritant-mediated. (See <a class="local">'Types'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathology</strong> – In the case of immunologically mediated occupational asthma, the pathology in the airways is similar to that seen in patients with nonoccupational asthma. The pathologic changes may persist for weeks to years after cessation of exposure. For nonimmunological occupational asthma, there is a predominance of denudation of epithelium in the acute phase with a long-term increase in basement membrane thickness. (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiologic mechanism</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>High molecular weight agents</strong> – High molecular weight agents (eg, animal proteins and flour) act as complete antigens and induce the production of specific IgE antibodies, which are felt to play a key role in disease pathogenesis, similar to that of common inhalant allergens (eg, dust mite) in allergic asthma. (See <a class="local">'Immunologic mechanisms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Low molecular weight agents</strong> – Certain low molecular weight (LMW) occupational agents, including platinum salts, trimellitic anhydride, and other acid anhydrides, also induce specific IgE antibodies, probably by acting as haptens, binding with proteins to form functional antigens. Most LMW agents may also cause occupational asthma through non-IgE-mediated mechanisms. (See <a class="local">'Immunologic mechanisms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Irritants</strong> – Occupational asthma due to exposure to irritants (eg, chlorine, ammonia, smoke) may result from nonimmunologic mechanisms such as denudation of the airway epithelium, direct beta-2 adrenergic receptor inhibition, or elaboration of substance P by injured sensory nerves. Nonimmunologic occupational asthma is characterized by the absence of a latency period and by exposure to a high level of the irritant agent. (See <a class="local">'Nonimmunologic mechanisms'</a> above and  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p></p><p class="headingAnchor" id="H12094113"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Moira Chan Yeung, MD, Jean-Luc Malo, MD, André Cartier, MD, and Louis-Philippe Boulet, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Bernstein, IL, Chan-Yeung, et al. Asthma in the workplace, 3rd, Taylor and Francis, New York 2006.</li><li class="breakAll">Tarlo SM, Vandenplas O, Bernstein DI, Malo JL. Asthma in the Workplace, 5th, CRC Press, Boca Raton 2021.</li><li><a class="nounderline abstract_t">Maestrelli P, Boschetto P, Fabbri LM, Mapp CE. Mechanisms of occupational asthma. J Allergy Clin Immunol 2009; 123:531.</a></li><li><a class="nounderline abstract_t">Corren J. Asthma phenotypes and endotypes: an evolving paradigm for classification. Discov Med 2013; 15:243.</a></li><li><a class="nounderline abstract_t">Mason P, Scarpa MC, Liviero F, et al. Distinct Clinical Phenotypes of Occupational Asthma due to Diisocyanates. J Occup Environ Med 2017; 59:539.</a></li><li><a class="nounderline abstract_t">Quirce S, Sastre J. Occupational asthma: clinical phenotypes, biomarkers, and management. Curr Opin Pulm Med 2019; 25:59.</a></li><li><a class="nounderline abstract_t">Vandenplas O, Godet J, Hurdubaea L, et al. Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma? Allergy 2019; 74:261.</a></li><li><a class="nounderline abstract_t">Lipińska-Ojrzanowska A, Marcinkiewicz A, Walusiak-Skorupa J. Usefulness of Biomarkers in Work-Related Airway Disease. Curr Treat Options Allergy 2017; 4:181.</a></li><li><a class="nounderline abstract_t">Ojanguren I, Moullec G, Hobeika J, et al. Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma. PLoS One 2018; 13:e0193144.</a></li><li><a class="nounderline abstract_t">Ojanguren I, Moullec G, Hobeika J, et al. Correction: Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma. PLoS One 2018; 13:e0195648.</a></li><li><a class="nounderline abstract_t">Boulet LP, Boutet M, Laviolette M, et al. Airway inflammation after removal from the causal agent in occupational asthma due to high and low molecular weight agents. Eur Respir J 1994; 7:1567.</a></li><li><a class="nounderline abstract_t">Bentley, AM, Maestrelli, et al. Immunochemistry of the bronchial mucosa in occupational, intrinsic and extrinsic asthma. J Allergy Clin Immunol 1991; 87:246.</a></li><li><a class="nounderline abstract_t">Frew AJ, Chan H, Lam S, Chan-Yeung M. Bronchial inflammation in occupational asthma due to western red cedar. Am J Respir Crit Care Med 1995; 151:340.</a></li><li><a class="nounderline abstract_t">Zhu Z, Zheng T, Homer RJ, et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004; 304:1678.</a></li><li><a class="nounderline abstract_t">Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 2006; 129:1068.</a></li><li><a class="nounderline abstract_t">Saetta M, Di Stefano A, Maestrelli P, et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1992; 145:160.</a></li><li><a class="nounderline abstract_t">Boulet LP, Chakir J, Dubé J, et al. Airway inflammation and structural changes in airway hyper-responsiveness and asthma: an overview. Can Respir J 1998; 5:16.</a></li><li><a class="nounderline abstract_t">Maghni K, Lemière C, Ghezzo H, et al. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004; 169:367.</a></li><li><a class="nounderline abstract_t">Sumi Y, Foley S, Daigle S, et al. Structural changes and airway remodelling in occupational asthma at a mean interval of 14 years after cessation of exposure. Clin Exp Allergy 2007; 37:1781.</a></li><li><a class="nounderline abstract_t">Lemière C, Malo JL, Boutet M. Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessment. Eur Respir J 1997; 10:241.</a></li><li><a class="nounderline abstract_t">Demnati R, Fraser R, Ghezzo H, et al. Time-course of functional and pathological changes after a single high acute inhalation of chlorine in rats. Eur Respir J 1998; 11:922.</a></li><li><a class="nounderline abstract_t">Martin JG, Campbell HR, Iijima H, et al. Chlorine-induced injury to the airways in mice. Am J Respir Crit Care Med 2003; 168:568.</a></li><li><a class="nounderline abstract_t">Gautrin D, Boulet LP, Boutet M, et al. Is reactive airways dysfunction syndrome a variant of occupational asthma? J Allergy Clin Immunol 1994; 93:12.</a></li><li><a class="nounderline abstract_t">Chang-Yeung M, Lam S, Kennedy SM, Frew AJ. Persistent asthma after repeated exposure to high concentrations of gases in pulpmills. Am J Respir Crit Care Med 1994; 149:1676.</a></li><li><a class="nounderline abstract_t">Malo JL, L'archevêque J, Castellanos L, et al. Long-term outcomes of acute irritant-induced asthma. Am J Respir Crit Care Med 2009; 179:923.</a></li><li><a class="nounderline abstract_t">Takeda N, Maghni K, Daigle S, et al. Long-term pathologic consequences of acute irritant-induced asthma. J Allergy Clin Immunol 2009; 124:975.</a></li><li class="breakAll">Maestrelli P, Wisniewski AV, Carlsten C, et al. Mechanisms, genetics, and pathophysiology. In: Asthma in the Workplace, 5th, Tarlo SM, Vandenplas O, Bernstein DI, Malo J (Eds), CRC press Taylor &amp; Francis Group, Boca Raton 2022. p.35.</li><li><a class="nounderline abstract_t">Yucesoy B, Johnson VJ, Lummus ZL, et al. Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma. J Occup Environ Med 2014; 56:382.</a></li><li><a class="nounderline abstract_t">Mapp CE, Fryer AA, De Marzo N, et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol 2002; 109:867.</a></li><li><a class="nounderline abstract_t">Piirilä P, Wikman H, Luukkonen R, et al. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 2001; 11:437.</a></li><li><a class="nounderline abstract_t">Wikman H, Piirilä P, Rosenberg C, et al. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics 2002; 12:227.</a></li><li><a class="nounderline abstract_t">Yucesoy B, Kissling GE, Johnson VJ, et al. N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma. J Occup Environ Med 2015; 57:1331.</a></li><li><a class="nounderline abstract_t">Yucesoy B, Johnson VJ, Lummus ZL, et al. Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma. Toxicol Sci 2012; 129:166.</a></li><li><a class="nounderline abstract_t">Ye YM, Kang YM, Kim SH, et al. Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma. Clin Exp Allergy 2006; 36:1153.</a></li><li><a class="nounderline abstract_t">Bernstein DI, Kissling GE, Khurana Hershey G, et al. Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α. J Allergy Clin Immunol 2011; 128:418.</a></li><li><a class="nounderline abstract_t">Bernstein DI. Genetics of occupational asthma. Curr Opin Allergy Clin Immunol 2011; 11:86.</a></li><li><a class="nounderline abstract_t">Kim SH, Cho BY, Park CS, et al. Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis. Clin Exp Allergy 2009; 39:203.</a></li><li><a class="nounderline abstract_t">Bernstein DI, Kashon M, Lummus ZL, et al. CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. Toxicol Sci 2013; 131:242.</a></li><li><a class="nounderline abstract_t">Yucesoy B, Kaufman KM, Lummus ZL, et al. Genome-Wide Association Study Identifies Novel Loci Associated With Diisocyanate-Induced Occupational Asthma. Toxicol Sci 2015; 146:192.</a></li><li><a class="nounderline abstract_t">Bernstein DI, Lummus ZL, Kesavalu B, et al. Genetic variants with gene regulatory effects are associated with diisocyanate-induced asthma. J Allergy Clin Immunol 2018; 142:959.</a></li><li><a class="nounderline abstract_t">Yucesoy B, Kashon ML, Johnson VJ, et al. Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma. J Immunotoxicol 2016; 13:119.</a></li><li><a class="nounderline abstract_t">Ouyang B, Bernstein DI, Lummus ZL, et al. Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma. Toxicol Sci 2013; 133:218.</a></li><li><a class="nounderline abstract_t">Pacheco KA, Rose CS, Silveira LJ, et al. Gene-environment interactions influence airways function in laboratory animal workers. J Allergy Clin Immunol 2010; 126:232.</a></li><li><a class="nounderline abstract_t">Lummus ZL, Wisnewski AV, Bernstein DI. Pathogenesis and disease mechanisms of occupational asthma. Immunol Allergy Clin North Am 2011; 31:699.</a></li><li><a class="nounderline abstract_t">Jones MG, Floyd A, Nouri-Aria KT, et al. Is occupational asthma to diisocyanates a non-IgE-mediated disease? J Allergy Clin Immunol 2006; 117:663.</a></li><li><a class="nounderline abstract_t">Sjåheim TB, Bjørtuft Ø, Drabløs PA, et al. Increased bronchial density of CD25+Foxp3+ regulatory T cells in occupational asthma: relationship to current smoking. Scand J Immunol 2013; 77:398.</a></li><li><a class="nounderline abstract_t">Redlich CA, Herrick CA. Lung/skin connections in occupational lung disease. Curr Opin Allergy Clin Immunol 2008; 8:115.</a></li><li><a class="nounderline abstract_t">Tsui HC, Ronsmans S, De Sadeleer LJ, et al. Skin Exposure Contributes to Chemical-Induced Asthma: What is the Evidence? A Systematic Review of Animal Models. Allergy Asthma Immunol Res 2020; 12:579.</a></li><li class="breakAll">Newman-Taylor, AJ, Yucesov, B. Genetics and Occupational Asthma. In: Asthma in the Workplace, 3rd, Taylor and Francis, New York 2006. p.87.</li><li><a class="nounderline abstract_t">Pepys J. New tests to assess lung function. inhalation challenge tests in asthma. N Engl J Med 1975; 293:758.</a></li><li><a class="nounderline abstract_t">Perrin B, Cartier A, Ghezzo H, et al. Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents. J Allergy Clin Immunol 1991; 87:630.</a></li><li><a class="nounderline abstract_t">Wiszniewska M, Nowakowska-Świrta E, Pałczyński C, Walusiak-Skorupa J. Diagnosing of bakers' respiratory allergy: is specific inhalation challenge test essential? Allergy Asthma Proc 2011; 32:111.</a></li><li><a class="nounderline abstract_t">Karol MH, Alarie Y. Antigens which detect IgE antibodies in workers sensitive to toluene diisocyanate. Clin Allergy 1980; 10:101.</a></li><li><a class="nounderline abstract_t">Wisnewski AV, Jones M. Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease? Clin Exp Allergy 2010; 40:1155.</a></li><li class="breakAll">Jolly A, Maestrelli P, Redlich C, et al. Polyisocyanates and their Prepolymers. In: Asthma in the Workplace, 5th, CRC Press, Boca Raton 2022. p.179.</li><li><a class="nounderline abstract_t">Tee RD, Cullinan P, Welch J, et al. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol 1998; 101:709.</a></li><li><a class="nounderline abstract_t">Park HS, Kim HY, Lee SK, et al. Diverse profiles of specific IgE response to toluene diisocyanate (TDI)-human serum albumin conjugate in TDI-induced asthma patients. J Korean Med Sci 2001; 16:57.</a></li><li><a class="nounderline abstract_t">Wisnewski AV, Lemus R, Karol MH, Redlich CA. Isocyanate-conjugated human lung epithelial cell proteins: A link between exposure and asthma? J Allergy Clin Immunol 1999; 104:341.</a></li><li><a class="nounderline abstract_t">Ye YM, Kang YM, Kim SH, et al. Probable role of Beta 2-adrenergic receptor gene haplotype in toluene diisocyanate-induced asthma. Allergy Asthma Immunol Res 2010; 2:260.</a></li><li><a class="nounderline abstract_t">Agius RM. Why are some low-molecular-weight agents asthmagenic. Occup Med 2000; 15:369.</a></li><li><a class="nounderline abstract_t">Jarvis J, Seed MJ, Elton R, et al. Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds. Occup Environ Med 2005; 62:243.</a></li><li><a class="nounderline abstract_t">Jarvis J, Seed MJ, Stocks SJ, Agius RM. A refined QSAR model for prediction of chemical asthma hazard. Occup Med (Lond) 2015; 65:659.</a></li><li><a class="nounderline abstract_t">Frew A, Chan H, Dryden P, et al. Immunologic studies of the mechanisms of occupational asthma caused by western red cedar. J Allergy Clin Immunol 1993; 92:466.</a></li><li><a class="nounderline abstract_t">Tse KS, Chan H, Chan-Yeung M. Specific IgE antibodies in workers with occupational asthma due to western red cedar. Clin Allergy 1982; 12:249.</a></li><li><a class="nounderline abstract_t">Bernstein DI, Cartier A, Côté J, et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 2002; 166:445.</a></li><li><a class="nounderline abstract_t">Maestrelli P, Del Prete GF, De Carli M, et al. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health 1994; 20:376.</a></li><li><a class="nounderline abstract_t">Hur GY, Sheen SS, Kang YM, et al. Histamine release and inflammatory cell infiltration in airway Mucosa in methylene diphenyl diisocyanate (MDI)-induced occupational asthma. J Clin Immunol 2008; 28:571.</a></li><li><a class="nounderline abstract_t">Frew A, Chang JH, Chan H, et al. T-lymphocyte responses to plicatic acid-human serum albumin conjugate in occupational asthma caused by western red cedar. J Allergy Clin Immunol 1998; 101:841.</a></li><li><a class="nounderline abstract_t">Shirakawa T, Kusaka Y, Fujimura N, et al. Hard metal asthma: cross immunological and respiratory reactivity between cobalt and nickel? Thorax 1990; 45:267.</a></li><li><a class="nounderline abstract_t">Finotto S, Fabbri LM, Rado V, et al. Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate. Br J Ind Med 1991; 48:116.</a></li><li><a class="nounderline abstract_t">Raulf-Heimsoth M, Merget R, Rihs HP, et al. T-cell receptor repertoire expression in workers with occupational asthma due to platinum salt. Eur Respir J 2000; 16:871.</a></li><li><a class="nounderline abstract_t">Regal JF. Immunologic effector mechanisms in animal models of occupational asthma. J Immunotoxicol 2004; 1:25.</a></li><li><a class="nounderline abstract_t">Yu G, Zhang Y, Wang X, et al. Thymic stromal lymphopoietin (TSLP) and Toluene-diisocyanate-induced airway inflammation: Alleviation by TSLP neutralizing antibody. Toxicol Lett 2019; 317:59.</a></li><li><a class="nounderline abstract_t">Kouadio K, Zheng KC, Tuekpe MK, et al. Airway inflammatory and immunological events in a rat model exposed to toluene diisocyanate. Food Chem Toxicol 2005; 43:1281.</a></li><li><a class="nounderline abstract_t">Herrick CA, Das J, Xu L, et al. Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: genetic control of TH2-induced lung inflammation. J Allergy Clin Immunol 2003; 111:1087.</a></li><li><a class="nounderline abstract_t">Long CM, Marshall NB, Lukomska E, et al. A Role for Regulatory T Cells in a Murine Model of Epicutaneous Toluene Diisocyanate Sensitization. Toxicol Sci 2016; 152:85.</a></li><li><a class="nounderline abstract_t">Pollaris L, Van Den Broucke S, Decaesteker T, et al. Dermal exposure determines the outcome of repeated airway exposure in a long-term chemical-induced asthma-like mouse model. Toxicology 2019; 421:84.</a></li><li><a class="nounderline abstract_t">Butcher BT, Karr RM, O'Neil CE, et al. Inhalation challenge and pharmacologic studies of toluene diisocyanate (TDI)-sensitive workers. J Allergy Clin Immunol 1979; 64:146.</a></li><li><a class="nounderline abstract_t">Leroyer C, Perfetti L, Cartier A, Malo JL. Can reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to "sensitisation" to isocyanates? Thorax 1998; 53:152.</a></li><li class="breakAll">Bernstein JA, Dumas O, de Blay F, et al. Irritant-induced asthma and reactive airways dysfunction syndrome. In: Asthma in the Workplace, 5th, Tarlo S, Bernstein D, Malo JL, Vandenplas O (Eds), CRC press Taylor &amp; Francis Group, Boca Raton 2022. p.251.</li><li><a class="nounderline abstract_t">Chan-Yeung M, Giclas PC, Henson PM. Activation of complement by plicatic acid, the chemical compound responsible for asthma due to western red cedar (Thuja plicata). J Allergy Clin Immunol 1980; 65:333.</a></li><li><a class="nounderline abstract_t">Chitano P, Di Blasi P, Lucchini RE, et al. The effects of toluene diisocyanate and of capsaicin on human bronchial smooth muscle in vitro. Eur J Pharmacol 1994; 270:167.</a></li><li><a class="nounderline abstract_t">Mapp CE, Graf PD, Boniotti A, Nadel JA. Toluene diisocyanate contracts guinea pig bronchial smooth muscle by activating capsaicin-sensitive sensory nerves. J Pharmacol Exp Ther 1991; 256:1082.</a></li><li><a class="nounderline abstract_t">Dumas O, Le Moual N. Do chronic workplace irritant exposures cause asthma? Curr Opin Allergy Clin Immunol 2016; 16:75.</a></li><li><a class="nounderline abstract_t">Freitas AS, Simoneti CS, Ferraz E, et al. Exposure to high endotoxin concentration increases wheezing prevalence among laboratory animal workers: a cross-sectional study. BMC Pulm Med 2016; 16:69.</a></li><li><a class="nounderline abstract_t">Perfetti L, Bramé B, Ferrari M, Moscato G. Occupational asthma (OA) with sensitization to diphenylmethane diisocyanate (MDI) presenting at the onset like a reactive airways dysfunction syndrome (RADS). Am J Ind Med 2003; 44:325.</a></li><li class="breakAll">Maestrelli P, Yucesoy B, Park HS, Wisnewski A. Mechanism, Genetics and Pathophysiology. In: Asthma in the workplace, 4th, Malo J, Chan-Yeung M, Bernstein D (Eds), CRC Press, New York 2013.</li></ol></div><div id="topicVersionRevision">Topic 538 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Bernstein, IL, Chan-Yeung, et al. Asthma in the workplace, 3rd, Taylor and Francis, New York 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Tarlo SM, Vandenplas O, Bernstein DI, Malo JL. Asthma in the Workplace, 5th, CRC Press, Boca Raton 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19281901" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Mechanisms of occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23636141" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Asthma phenotypes and endotypes: an evolving paradigm for classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28598931" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Distinct Clinical Phenotypes of Occupational Asthma due to Diisocyanates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30320613" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Occupational asthma: clinical phenotypes, biomarkers, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29956349" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28680796" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Usefulness of Biomarkers in Work-Related Airway Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29499062" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29617436" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Correction: Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7995383" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Airway inflammation after removal from the causal agent in occupational asthma due to high and low molecular weight agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Immunochemistry of the bronchial mucosa in occupational, intrinsic and extrinsic asthma</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7842189" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Bronchial inflammation in occupational asthma due to western red cedar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15192232" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16608960" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1309963" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9556503" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Airway inflammation and structural changes in airway hyper-responsiveness and asthma: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14578217" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Airway inflammation after cessation of exposure to agents causing occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17900308" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Structural changes and airway remodelling in occupational asthma at a mean interval of 14 years after cessation of exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9032521" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9623698" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Time-course of functional and pathological changes after a single high acute inhalation of chlorine in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12724121" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Chlorine-induced injury to the airways in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8308178" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Is reactive airways dysfunction syndrome a variant of occupational asthma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8004329" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Persistent asthma after repeated exposure to high concentrations of gases in pulpmills.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19234102" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Long-term outcomes of acute irritant-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19895985" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Long-term pathologic consequences of acute irritant-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19895985" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Long-term pathologic consequences of acute irritant-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24709764" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11994713" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11470996" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11927838" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26641831" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22610343" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16961715" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21489615" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptorα.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21325943" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Genetics of occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19187332" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22977168" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25918132" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Genome-Wide Association Study Identifies Novel Loci Associated With Diisocyanate-Induced Occupational Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29969634" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Genetic variants with gene regulatory effects are associated with diisocyanate-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25721048" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23535363" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Interferon-γpromoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20579716" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Gene-environment interactions influence airways function in laboratory animal workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21978852" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pathogenesis and disease mechanisms of occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16522468" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Is occupational asthma to diisocyanates a non-IgE-mediated disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23421612" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Increased bronchial density of CD25+Foxp3+ regulatory T cells in occupational asthma: relationship to current smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18317018" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Lung/skin connections in occupational lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32400126" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Skin Exposure Contributes to Chemical-Induced Asthma: What is the Evidence? A Systematic Review of Animal Models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32400126" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Skin Exposure Contributes to Chemical-Induced Asthma: What is the Evidence? A Systematic Review of Animal Models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1160954" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : New tests to assess lung function. inhalation challenge tests in asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2005315" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21439164" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Diagnosing of bakers' respiratory allergy: is specific inhalation challenge test essential?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6244907" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Antigens which detect IgE antibodies in workers sensitive to toluene diisocyanate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20545707" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20545707" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9600510" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Specific IgE to isocyanates: a useful diagnostic role in occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11289402" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Diverse profiles of specific IgE response to toluene diisocyanate (TDI)-human serum albumin conjugate in TDI-induced asthma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10452755" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Isocyanate-conjugated human lung epithelial cell proteins: A link between exposure and asthma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20885911" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Probable role of Beta 2-adrenergic receptor gene haplotype in toluene diisocyanate-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10769343" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Why are some low-molecular-weight agents asthmagenic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15778257" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26209225" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A refined QSAR model for prediction of chemical asthma hazard.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8360398" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Immunologic studies of the mechanisms of occupational asthma caused by western red cedar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6179654" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Specific IgE antibodies in workers with occupational asthma due to western red cedar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12186818" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7863302" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18484168" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Histamine release and inflammatory cell infiltration in airway Mucosa in methylene diphenyl diisocyanate (MDI)-induced occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9648713" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : T-lymphocyte responses to plicatic acid-human serum albumin conjugate in occupational asthma caused by western red cedar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2356553" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Hard metal asthma: cross immunological and respiratory reactivity between cobalt and nickel?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1847821" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11153586" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : T-cell receptor repertoire expression in workers with occupational asthma due to platinum salt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18958638" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Immunologic effector mechanisms in animal models of occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31577921" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Thymic stromal lymphopoietin (TSLP) and Toluene-diisocyanate-induced airway inflammation: Alleviation by TSLP neutralizing antibody.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15950818" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Airway inflammatory and immunological events in a rat model exposed to toluene diisocyanate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12743574" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: genetic control of TH2-induced lung inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27103660" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A Role for Regulatory T Cells in a Murine Model of Epicutaneous Toluene Diisocyanate Sensitization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31071364" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Dermal exposure determines the outcome of repeated airway exposure in a long-term chemical-induced asthma-like mouse model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/222827" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Inhalation challenge and pharmacologic studies of toluene diisocyanate (TDI)-sensitive workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9624303" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Can reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to "sensitisation" to isocyanates?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9624303" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Can reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to "sensitisation" to isocyanates?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6768786" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Activation of complement by plicatic acid, the chemical compound responsible for asthma due to western red cedar (Thuja plicata).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7518777" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : The effects of toluene diisocyanate and of capsaicin on human bronchial smooth muscle in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1706429" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Toluene diisocyanate contracts guinea pig bronchial smooth muscle by activating capsaicin-sensitive sensory nerves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26914673" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Do chronic workplace irritant exposures cause asthma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27153990" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Exposure to high endotoxin concentration increases wheezing prevalence among laboratory animal workers: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12929154" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Occupational asthma (OA) with sensitization to diphenylmethane diisocyanate (MDI) presenting at the onset like a reactive airways dysfunction syndrome (RADS).</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
